Abstract
Despite global control efforts, tuberculosis remains the leading infectious cause of death, with rising incidence, pediatric cases, and drug-resistant strains posing major public health challenges. Mycobacteria, including Mycobacterium tuberculosis, possess a lipid-rich, dual-membrane cell envelope that contributes to their impermeability, drug resistance, and unique pathogenic mechanisms. Some lipids play key roles in modulating host immune responses, enabling survival within macrophages, and promoting granuloma formation. Since it is known that lipid remodeling of the cell envelope is correlated with the antibiotics tolerance in mycobacteria we used liquid chromatography coupled to mass spectrometry to analyze the lipid profiles of M. tuberculosis clinical isolates with diverse drug-resistance characteristics in order to investigate if there is any link between Mtb lipids composition, its drugs susceptibility and the antimycobacterial activity of natural small molecules used in combination with first line antibiotics. The results showed that among cross combinations of antibiotics and natural products (piperine and thymoquinone) the potentiation of antimycobacterial activity was obtained in all strains only for rifampicin. Drug-resistant isolates presented the shift in glycerophospholipids building the inner membrane towards molecules with shorter acyl chains, but the decreased membrane hydrophobic thickness was compensated in some strains by increased membrane rigidity. The pXDR/XDR isolates accumulated mycobactins loaded iron and showed dysregulation in the production of phthiocerol/phthiodiolone dimycocerosates and triacylglycerols.
Data availability
The data that support the findings of this study are available from Zenodo, DOI: https://doi.org/10.5281/zenodo.17214535.
References
Batt, S. M., Minnikin, D. E. & Besra, G. S. The thick waxy coat of mycobacteria, a protective layer against antibiotics and the host’s immune system. Biochem. J. 477 (10), 1983–2006. https://doi.org/10.1042/BCJ20200194 (2020). (From NLM Medline).
Layre, E., Al-Mubarak, R. & Belisle, J. T. Branch Moody, D. Mycobacterial Lipidomics. Microbiol. Spectr. 2 (3). https://doi.org/10.1128/microbiolspec (2014). (MGM2-0033-2013 From NLM Medline).
Bansal-Mutalik, R. & Nikaido, H. Mycobacterial outer membrane is a lipid bilayer and the inner membrane is unusually rich in diacylphosphatidylinositol dimannosides. PNAS 111, 4958–4963 (2014).
Jackson, M. The mycobacterial cell envelope-lipids. Cold Spring Harb Perspect. Med. 4 (10). https://doi.org/10.1101/cshperspect.a021105 (2014). From NLM Medline.
Sartain, M. J., Dick, D. L., Rithner, C. D., Crick, D. C. & Belisle, J. T. Lipidomic analyses of Mycobacterium tuberculosis based on accurate mass measurements and the novel Mtb LipidDB. J. Lipid Res. 5, 861–672. https://doi.org/10.1194/jlr.M010363 (2011).
Nguyen, P. P., Kado, T., Prithviraj, M., Siegrist, M. S. & Morita, Y. S. Inositol acylation of phosphatidylinositol mannosides: a rapid mass response to membrane fluidization in mycobacteria. J. Lipid Res. 63 (9), 100262. https://doi.org/10.1016/j.jlr.2022.100262 (2022).
Angala, S. K., Belardinelli, J. M., Huc-Claustre, E., Wheat, W. H. & Jackson, M. The cell envelope glycoconjugates of Mycobacterium tuberculosis. Crit. Rev. Biochem. Mol. Biol. 49 (5), 361–399. https://doi.org/10.3109/10409238.2014.925420 (2014).
Queiroz, A. & Riley, L. W. Bacterial immunostat: Mycobacterium tuberculosis lipids and their role in the host immune response. Rev. Soc. Bras. Med. Trop. 50 (1), 9–18. https://doi.org/10.1590/0037-8682-0230-2016 (2017).
Ghazaei, C. Mycobacterium tuberculosis and lipids: Insights into molecular mechanisms from persistence to virulence. J. Res. Med. Sci. 23 (63). https://doi.org/10.4103/jrms.JRMS_904_17 (2018). From NLM PubMed-not-MEDLINE.
Ishikawa, E. et al. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J. Exp. Med. 206 (13), 2879–2888. https://doi.org/10.1084/jem.20091750 (2009).
Augenstreich, J. & Briken, V. Host cell targets of released lipid and secreted protein effectors of Mycobacterium tuberculosis. Front. Cell. Infect. Microbiol. 10, 595029. https://doi.org/10.3389/fcimb.2020.595029 (2020).
Takimoto, H. et al. Interferon-gamma independent formation of pulmonary granuloma in mice by injections with trehalose dimycolate (cord factor), lipoarabinomannan and phosphatidylinositol mannosides isolated from Mycobacterium tuberculosis. Clin. Exp. Immunol. 144 (1), 134–141. https://doi.org/10.1111/j.1365-2249.2006.03043.x (2006).
Reed, M. B. et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431 (7004), 84–87. https://doi.org/10.1038/nature02837 (2004).
Brodin, P. et al. High content phenotypic cell-based visual screen identifies Mycobacterium tuberculosis acyltrehalose-containing glycolipids involved in phagosome remodeling. PLoS Pathog. 6 (9), e1001100. https://doi.org/10.1371/journal.ppat.1001100 (2010).
Lee, K. S. et al. Diacyltrehalose of Mycobacterium tuberculosis inhibits lipopolysaccharide- and mycobacteria-induced proinflammatory cytokine production in human monocytic cells. FEMS Microbiol. Lett. 267 (1), 121–128. https://doi.org/10.1111/j.1574-6968.2006.00553.x (2007).
Saavedra, R., Segura, E., Leyva, R., Esparza, L. A. & Lopez-Marin, L. M. Mycobacterial di-O-acyl-trehalose inhibits mitogen- and antigen-induced proliferation of murine T cells in vitro. Clin. Diagn. Lab. Immunol. 8 (6), 1081–1088. https://doi.org/10.1128/CDLI.8.6.1-91-1088.2001 (2001).
Osman, M. M., Pagan, A. J., Shanahan, J. K. & Ramakrishnan, L. Mycobacterium marinum phthiocerol dimycocerosates enhance macrophage phagosomal permeabilization and membrane damage. PLoS One. 15 (7), e0233252. https://doi.org/10.1371/journal.pone.0233252 (2020).
Rens, C., Chao, J. D., Sexton, D. L., Tocheva, E. I. & Av-Gay, Y. Roles for phthiocerol dimycocerosate lipids in Mycobacterium tuberculosis pathogenesis. Microbiol. (Reading). 167 (3). https://doi.org/10.1099/mic.0.001042 (2021).
Wang, H., Liu, D. & Zhou, X. Effect of mycolic acids on host immunity and lipid metabolism. Int. J. Mol. Sci. 25 (1). https://doi.org/10.3390/ijms25010396 (2023).
Larrouy-Maumus, G. et al. Cell-envelope remodeling as a determinant of phenotypic antibacterial tolerance in Mycobacterium tuberculosis. ACS Infect. Dis. 2 (5), 352–360. https://doi.org/10.1021/acsinfecdis.5b00148 (2016).
Menon, A. P., Lee, T. H., Aguilar, M. I. & Kapoor, S. Decoding the role of mycobacterial lipid remodelling and membrane dynamics in antibiotic tolerance. Chem. Sci. 15 (45), 19084–19093. https://doi.org/10.1039/d4sc06618a (2024). From NLM Publisher.
Block, A. M. et al. Mycobacterium tuberculosis requires the outer membrane lipid phthiocerol dimycocerosate for starvation-induced antibiotic tolerance. mSystems. 8(1), e0069922. https://doi.org/10.1128/msystems.00699-22 (2023).
Charalambous, K., Miller, D., Curnow, P. & Booth, P. J. Lipid bilayer composition influences small multidrug transporters. BMC Biochem. 9, 31. https://doi.org/10.1186/1471-2091-9-31 (2008).
Liu, J. et al. Mutations in Efflux Pump Rv1258c (Tap) Cause Resistance to Pyrazinamide, Isoniazid, and Streptomycin in M. tuberculosis. Front. Microbiol. 10, 216. https://doi.org/10.3389/fmicb.2019.00216 (2019).
Sharma, S. et al. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. J. Antimicrob. Chemother. 65 (8), 1694–1701. https://doi.org/10.1093/jac/dkq186 (2010).
Brammachary, U. et al. Mechanisms and action of drug resistance on Mycobacterium tuberculosis. In New Insights in Antibiotic Resistance and Pneumococcal Vaccines (eds Mustafa, G. & Saxena, S. K.) (IntechOpen, 2022).
Carel, C. et al. Mycobacterium tuberculosis proteins involved in mycolic acid synthesis and transport localize dynamically to the old growing pole and septum. PLoS One. 9 (5), e97148. https://doi.org/10.1371/journal.pone.0097148 (2014). From NLM Medline.
Seidel, M., Alderwick, L. J., Sahm, H., Besra, G. S. & Eggeling, L. Topology and mutational analysis of the single Emb arabinofuranosyltransferase of Corynebacterium glutamicum as a model of Emb proteins of Mycobacterium tuberculosis. Glycobiology 17 (2), 210–219. https://doi.org/10.1093/glycob/cwl066 (2007). From NLM Medline.
Murase, L. S. et al. Possible binding of piperine in Mycobacterium tuberculosis RNA polymerase and rifampin synergism. Antimicrob. Agents Chemother. 63 (11). https://doi.org/10.1128/AAC.02520-18 (2019).
Campbell, E. A. et al. Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell 104 (6), 901–912. https://doi.org/10.1016/s0092-8674(01)00286-0 (2001).
Jankowski, G. et al. Molecular insight into thymoquinone mechanism of action against Mycobacterium tuberculosis. Front. Microbiol. 15, 1353875. https://doi.org/10.3389/fmicb.2024.1353875 (2024).
Yelamanchi, S. D. et al. Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis. Metabolites. 12 (6). https://doi.org/10.3390/metabo12060493 (2022).
Jackson, M., Crick, D. C. & Brennan, P. J. Phosphatidylinositol is an essential phospholipid of mycobacteria. J. Biol. Chem. 275, 30092–30099 (2000).
Frallicciardi, J., Melcr, J., Siginou, P., Marrink, S. J. & Poolman, B. Membrane thickness, lipid phase and sterol type are determining factors in the permeability of membranes to small solutes. Nat. Commun. 13 (1), 1605. https://doi.org/10.1038/s41467-022-29272-x (2022). From NLM Medline.
Slayden, R. A. & Barry, C. E. 3 The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis. Tuberculosis (Edinb). 82 (4–5), 149–160. https://doi.org/10.1054/tube.2002.0333 (2002). From NLM Medline.
Augenstreich, J. et al. Phthiocerol dimycocerosates from mycobacterium tuberculosis increase the membrane activity of bacterial effectors and host receptors. Front. Cell. Infect. Microbiol. 10, 420. https://doi.org/10.3389/fcimb.2020.00420 (2020). From NLM Medline.
Camacho, L. R. et al. Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J. Biol. Chem. 276 (23), 19845–19854. https://doi.org/10.1074/jbc.M100662200 (2001).
Kirksey, M. A. et al. Spontaneous phthiocerol dimycocerosate-deficient variants of Mycobacterium tuberculosis are susceptible to gamma interferon-mediated immunity. Infect. Immun. 79 (7), 2829–2838. https://doi.org/10.1128/IAI.00097-11 (2011). From NLM Medline.
Mulholland, C. V. et al. M. The PDIM paradox of Mycobacterium tuberculosis: new solutions to a persistent problem. bioRxiv (2023). https://doi.org/10.1101/2023.10.16.562559.
SambandanD et al. Keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis. mBio. 4 https://doi.org/10.1128/mBio.00222-13 (2013).
Sabareesh, V. & Singh, G. Mass spectrometry based lipid(ome) analyzer and molecular platform: a new software to interpret and analyze electrospray and/or matrix-assisted laser desorption/ionization mass spectrometric data of lipids: a case study from Mycobacterium tuberculosis. J. Mass. Spectrom. 48 (4), 465–477. https://doi.org/10.1002/jms.3163 (2013). From NLM Medline.
Funding
The authors received funding for this work from The National Science Centre: UMO-2022/45/B/NZ7/00412. The funders had no role in study design, data collection and analysis, the decision to publish, or manuscript preparation.
Author information
Authors and Affiliations
Contributions
A.Z.: Conceptualization, investigation, resources, writing-original draft; writing-review and editing R.S.: Methodology, investigation, resources, writing-review and editing. G.J.: Investigation. M.Z.: Investigation. W.T.: Investigation. A.S.: Methodology, formal analysis. B.H.: Investigation, methodology, visualization. E.A.-K.: Writing-review and editing. P.P.: Validation, resources, writing-review and editing. M.C.-K.: Validation, resources, writing-review and editing. E.S.: Conceptualization; methodology, resources, validation, visualization, roles/writing-original draft supervision, project administration, funding acquisition.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zabost, A., Sawicki, R., Jankowski, G. et al. Linking lipid profile alterations to antibiotic tolerance and natural product synergy in drug-resistant Mycobacterium tuberculosis clinical isolates. Sci Rep (2026). https://doi.org/10.1038/s41598-026-41967-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-026-41967-5
